poziotinib

Law firms target Spectrum over lung cancer trial statements
Law firms target Spectrum over lung cancer trial statements
Fierce Biotech
Spectrum Pharmaceuticals
legal
class action lawsuits
clinical trials
poziotinib
Flag link:
FDA Action Alert: Spectrum, ImmunoGen, Scynexis and Y-mAbs
FDA Action Alert: Spectrum, ImmunoGen, Scynexis and Y-mAbs
BioSpace
FDA
Spectrum Pharmaceuticals
poziotinib
Immunogen
mirevtuximab soravtansine
Scynexis
Brexafemme
Y-mAbs
Omblastys
Flag link:
FDA advisory committee issues back to back negative votes on two cancer drugs
FDA advisory committee issues back to back negative votes on two cancer drugs
MedCity News
FDA
Spectrum Pharmaceuticals
Oncopeptides
clinical trials
poziotinib
Pepaxto
Multiple Myeloma
Flag link:
FDA panel votes against Spectrum's lung cancer drug
FDA panel votes against Spectrum's lung cancer drug
Reuters
FDA
Spectrum Pharrmaceuticals
non-small cell lung cancer
poziotinib
Flag link:
FDA slams Spectrum and Oncopeptides cancer drugs over efficacy concerns ahead of ODAC meeting
FDA slams Spectrum and Oncopeptides cancer drugs over efficacy concerns ahead of ODAC meeting
Endpoints
FDA
oncology
Spectrum Pharmaceuticals
Oncopeptides
poziotinib
Pepaxto
Flag link:
A turn-up for Spectrum’s book
A turn-up for Spectrum’s book
EP Vantage
poziotinib
Spectrum Pharmaceuticals
lung cancer
Takeda
Flag link:
Clinical developments over the Christmas period
Clinical developments over the Christmas period
EP Vantage
Google Health
Axsome
Spectrum Pharmaceuticals
Wave Life Sciences
Google DeepMind
AXS-07
WVE-120102
poziotinib
Flag link:
Spectrum Pharma Shares Slump After Lung-Cancer Drug Doesn't Meet Phase II Endpoint
Spectrum Pharma Shares Slump After Lung-Cancer Drug Doesn't Meet Phase II Endpoint
TheStreet.com
Spectrum Pharma
lung cancer
clinical trials
poziotinib
non-small cell lung cancer
Flag link:
Spectrum yanks marketing application for Neulasta rival after FDA demands more data
Spectrum yanks marketing application for Neulasta rival after FDA demands more data
Endpoints
Spectrum Pharmaceuticals
FDA
lung cancer
poziotinib
Neulasta
Flag link:
3 Biotech Stocks That Soared This Week
3 Biotech Stocks That Soared This Week
Motley Fool
AveXis
Abeona Therapeutics
Spectrum Pharmaceuticals
Novartis
M&A
poziotinib
EB-101
Flag link:
3 Biotech Stocks That Soared This Week: Are They Buys?
3 Biotech Stocks That Soared This Week: Are They Buys?
Motley Fool
biotech
Madrigal Pharmaceuticals
Spectrum Pharmaceuticals
poziotinib
ZX008
Zogenix
Flag link: